Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Norovirus vaccine development: next steps.

Atmar RL, Estes MK.

Expert Rev Vaccines. 2012 Sep;11(9):1023-5. doi: 10.1586/erv.12.78. No abstract available.

2.

Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Aliabadi N, Lopman BA, Parashar UD, Hall AJ.

Expert Rev Vaccines. 2015;14(9):1241-53. doi: 10.1586/14760584.2015.1073110. Epub 2015 Jul 29. Review.

PMID:
26224658
3.

Vaccine against norovirus.

Tan M, Jiang X.

Hum Vaccin Immunother. 2014;10(6):1449-56. doi: 10.4161/hv.28626. Epub 2014 May 5. Review.

PMID:
24718366
4.

Norovirus.

Robilotti E, Deresinski S, Pinsky BA.

Clin Microbiol Rev. 2015 Jan;28(1):134-64. doi: 10.1128/CMR.00075-14. Review.

5.

Noroviruses: epidemiology, immunity and prospects for prevention.

Pringle K, Lopman B, Vega E, Vinje J, Parashar UD, Hall AJ.

Future Microbiol. 2015;10(1):53-67. doi: 10.2217/fmb.14.102. Review.

PMID:
25598337
6.

A norovirus vaccine on the horizon?

Vinjé J.

J Infect Dis. 2010 Dec 1;202(11):1623-5. doi: 10.1086/657088. Epub 2010 Oct 27. No abstract available.

PMID:
20979457
7.

The potential economic value of a human norovirus vaccine for the United States.

Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY.

Vaccine. 2012 Nov 19;30(49):7097-104. doi: 10.1016/j.vaccine.2012.09.040. Epub 2012 Sep 28.

8.

Norovirus vaccine: one step closer.

Vesikari T, Blazevic V.

J Infect Dis. 2015 Mar 15;211(6):853-5. doi: 10.1093/infdis/jiu498. Epub 2014 Sep 9. No abstract available.

PMID:
25210142
9.

Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.

Tan M, Jiang X.

Nanomedicine (Lond). 2012 Jun;7(6):889-97. doi: 10.2217/nnm.12.62. Review.

10.

Duration of immunity to norovirus gastroenteritis.

Simmons K, Gambhir M, Leon J, Lopman B.

Emerg Infect Dis. 2013 Aug;19(8):1260-7. doi: 10.3201/eid1908.130472.

11.

Clinical profile of children with norovirus disease in rotavirus vaccine era.

Wikswo ME, Desai R, Edwards KM, Staat MA, Szilagyi PG, Weinberg GA, Curns AT, Lopman B, Vinjé J, Parashar UD, Payne DC, Hall AJ.

Emerg Infect Dis. 2013 Oct;19(10):1691-3. doi: 10.3201/eid1910.130448. No abstract available.

12.

The state of norovirus vaccines.

Debbink K, Lindesmith LC, Baric RS.

Clin Infect Dis. 2014 Jun;58(12):1746-52. doi: 10.1093/cid/ciu120. Epub 2014 Feb 27.

13.

Global age distribution of pediatric norovirus cases.

Shioda K, Kambhampati A, Hall AJ, Lopman BA.

Vaccine. 2015 Aug 7;33(33):4065-8. doi: 10.1016/j.vaccine.2015.05.051. Epub 2015 Jun 4.

14.

The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.

Lopman BA, Steele D, Kirkwood CD, Parashar UD.

PLoS Med. 2016 Apr 26;13(4):e1001999. doi: 10.1371/journal.pmed.1001999. eCollection 2016 Apr. Review.

15.

First vaccines targeting 'cruise ship virus' sail into clinical trials.

Willyard C.

Nat Med. 2013 Sep;19(9):1076-7. doi: 10.1038/nm0913-1076. No abstract available.

PMID:
24013733
16.

Cost-effectiveness of norovirus vaccination in children in Peru.

Mirelman AJ, Ballard SB, Saito M, Kosek MN, Gilman RH.

Vaccine. 2015 Jun 17;33(27):3084-91. doi: 10.1016/j.vaccine.2015.05.004. Epub 2015 May 15.

17.

A will to make it happen.

Sprinks J.

Nurs Stand. 2012 Sep 26-Oct 2;27(4):20-1.

PMID:
23101295
18.

Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.

Payne DC, Parashar UD, Lopman BA.

Curr Opin Pediatr. 2015 Feb;27(1):105-9. doi: 10.1097/MOP.0000000000000166. Review.

19.

The evolution of norovirus, the "gastric flu".

Lopman B, Zambon M, Brown DW.

PLoS Med. 2008 Feb;5(2):e42. doi: 10.1371/journal.pmed.0050042. Review. No abstract available.

20.

[Infection control practice for epidemic gastroenteritis in medical and welfare institutions for the elderly].

Oda M, Ito H, Izumi Y.

Nihon Ronen Igakkai Zasshi. 2010;47(1):92-3. Japanese. No abstract available.

Supplemental Content

Support Center